Stephanie L. Borgland - Publications

University of British Columbia, Vancouver, Vancouver, BC, Canada 
Addiction, Obesity, Synaptic plasticity

55 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Lam VM, Mielnik CA, Baimel C, Beerepoot P, Espinoza S, Sukhanov I, Horsfall W, Gainetdinov RR, Borgland SL, Ramsey AJ, Salahpour A. Behavioral Effects of a Potential Novel TAAR1 Antagonist. Frontiers in Pharmacology. 9: 953. PMID 30233365 DOI: 10.3389/fphar.2018.00953  1
2017 Thomas TS, Baimel C, Borgland SL. Opioid and hypocretin neuromodulation of VTA neuronal subpopulations. British Journal of Pharmacology. PMID 28849596 DOI: 10.1111/bph.13993  1
2017 Burma NE, Bonin RP, Leduc-Pessah H, Baimel C, Cairncross ZF, Mousseau M, Shankara JV, Stemkowski PL, Baimoukhametova D, Bains JS, Antle MC, Zamponi GW, Cahill CM, Borgland SL, DeKoninck Y, et al. Erratum: Blocking microglial pannexin-1 channels alleviates morphine withdrawal in rodents. Nature Medicine. 23: 788. PMID 28586339 DOI: 10.1038/nm0617-788c  1
2017 Lau BK, Cota D, Cristino L, Borgland SL. Endocannabinoid modulation of homeostatic and non-homeostatic feeding circuits. Neuropharmacology. PMID 28579186 DOI: 10.1016/j.neuropharm.2017.05.033  0.4
2017 Baimel C, Borgland SL. Hypocretin/Orexin and Plastic Adaptations Associated with Drug Abuse. Current Topics in Behavioral Neurosciences. PMID 28303403 DOI: 10.1007/7854_2016_44  1
2017 Mills F, Globa AK, Liu S, Cowan CM, Mobasser M, Phillips AG, Borgland SL, Bamji SX. Cadherins mediate cocaine-induced synaptic plasticity and behavioral conditioning. Nature Neuroscience. PMID 28192395 DOI: 10.1038/nn.4503  0.44
2017 Baimel C, Lau BK, Qiao M, Borgland SL. Projection-Target-Defined Effects of Orexin and Dynorphin on VTA Dopamine Neurons. Cell Reports. 18: 1346-1355. PMID 28178514 DOI: 10.1016/j.celrep.2017.01.030  1
2017 Burma NE, Bonin RP, Leduc-Pessah H, Baimel C, Cairncross ZF, Mousseau M, Shankara JV, Stemkowski PL, Baimoukhametova D, Bains JS, Antle MC, Zamponi GW, Cahill CM, Borgland SL, DeKoninck Y, et al. Blocking microglial pannexin-1 channels alleviates morphine withdrawal in rodents. Nature Medicine. PMID 28134928 DOI: 10.1038/nm.4281  1
2017 Thompson JL, Drysdale M, Baimel C, Kaur M, MacGowan T, Pitman KA, Borgland SL. Obesity-Induced Structural and Neuronal Plasticity in the Lateral Orbitofrontal Cortex. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 28042870 DOI: 10.1038/npp.2016.284  1
2016 Liu S, Globa AK, Mills F, Naef L, Qiao M, Bamji SX, Borgland SL. Consumption of palatable food primes food approach behavior by rapidly increasing synaptic density in the VTA. Proceedings of the National Academy of Sciences of the United States of America. PMID 26884159 DOI: 10.1073/pnas.1515724113  1
2015 Naef L, Pitman KA, Borgland SL. Mesolimbic dopamine and its neuromodulators in obesity and binge eating. Cns Spectrums. 1-10. PMID 26514168 DOI: 10.1017/S1092852915000693  0.48
2015 Thompson JL, Yang J, Lau B, Liu S, Baimel C, Kerr LE, Liu F, Borgland SL. Age-Dependent D1-D2 Receptor Coactivation in the Lateral Orbitofrontal Cortex Potentiates NMDA Receptors and Facilitates Cognitive Flexibility. Cerebral Cortex (New York, N.Y. : 1991). PMID 26405054 DOI: 10.1093/cercor/bhv222  1
2015 Pitman KA, Borgland SL. Changes in mu-opioid receptor expression and function in the mesolimbic system after long-term access to a palatable diet. Pharmacology & Therapeutics. PMID 26213108 DOI: 10.1016/j.pharmthera.2015.07.005  1
2015 Baimel C, Borgland SL. Orexin Signaling in the VTA Gates Morphine-Induced Synaptic Plasticity. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 35: 7295-303. PMID 25948277 DOI: 10.1523/JNEUROSCI.4385-14.2015  1
2015 Pitman KA, Borgland SL, MacLeod B, Puil E. Isovaline does not activate GABA(B) receptor-coupled potassium currents in GABA(B) expressing AtT-20 cells and cultured rat hippocampal neurons. Plos One. 10: e0118497. PMID 25706125 DOI: 10.1371/journal.pone.0118497  1
2015 Liu S, Borgland SL. Regulation of the mesolimbic dopamine circuit by feeding peptides. Neuroscience. 289: 19-42. PMID 25583635 DOI: 10.1016/j.neuroscience.2014.12.046  1
2015 Baimel C, Bartlett SE, Chiou LC, Lawrence AJ, Muschamp JW, Patkar O, Tung LW, Borgland SL. Orexin/hypocretin role in reward: implications for opioid and other addictions. British Journal of Pharmacology. 172: 334-48. PMID 24641197 DOI: 10.1111/bph.12639  1
2014 Pitman KA, Puil E, Borgland SL. GABAB modulation of dopamine release in the nucleus accumbens core. The European Journal of Neuroscience. 40: 3472-80. PMID 25229321 DOI: 10.1111/ejn.12733  1
2014 Ferris MJ, Milenkovic M, Liu S, Mielnik CA, Beerepoot P, John CE, España RA, Sotnikova TD, Gainetdinov RR, Borgland SL, Jones SR, Ramsey AJ. Sustained N-methyl-d-aspartate receptor hypofunction remodels the dopamine system and impairs phasic signaling. The European Journal of Neuroscience. 40: 2255-63. PMID 24754704 DOI: 10.1111/ejn.12594  1
2014 Muschamp JW, Hollander JA, Thompson JL, Voren G, Hassinger LC, Onvani S, Kamenecka TM, Borgland SL, Kenny PJ, Carlezon WA. Hypocretin (orexin) facilitates reward by attenuating the antireward effects of its cotransmitter dynorphin in ventral tegmental area. Proceedings of the National Academy of Sciences of the United States of America. 111: E1648-55. PMID 24706819 DOI: 10.1073/pnas.1315542111  1
2014 Brigidi GS, Sun Y, Beccano-Kelly D, Pitman K, Mobasser M, Borgland SL, Milnerwood AJ, Bamji SX. Palmitoylation of δ-catenin by DHHC5 mediates activity-induced synapse plasticity. Nature Neuroscience. 17: 522-32. PMID 24562000 DOI: 10.1038/nn.3657  1
2013 Liu S, Labouèbe G, Karunakaran S, Clee SM, Borgland SL. Effect of insulin on excitatory synaptic transmission onto dopamine neurons of the ventral tegmental area in a mouse model of hyperinsulinemia. Nutrition & Diabetes. 3: e97. PMID 24336291 DOI: 10.1038/nutd.2013.38  0.44
2013 Karatsoreos IN, Thaler JP, Borgland SL, Champagne FA, Hurd YL, Hill MN. Food for thought: hormonal, experiential, and neural influences on feeding and obesity. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 17610-6. PMID 24198352 DOI: 10.1523/JNEUROSCI.3452-13.2013  1
2013 Labouèbe G, Liu S, Dias C, Zou H, Wong JC, Karunakaran S, Clee SM, Phillips AG, Boutrel B, Borgland SL. Insulin induces long-term depression of ventral tegmental area dopamine neurons via endocannabinoids. Nature Neuroscience. 16: 300-8. PMID 23354329 DOI: 10.1038/nn.3321  1
2013 Thompson JL, Borgland SL. Presynaptic leptin action suppresses excitatory synaptic transmission onto ventral tegmental area dopamine neurons. Biological Psychiatry. 73: 860-8. PMID 23305991 DOI: 10.1016/j.biopsych.2012.10.026  1
2013 Liu S, Labouebe G, Borgland SL. Insulin Induces Long-term Depression in VTA DA Neurons via an Endocannabinoid-mediated Mechanism Catecholamine Research in the 21st Century: Abstracts and Graphical Abstracts, 10th International Catecholamine Symposium, 2012. 253. DOI: 10.1016/B978-0-12-800044-1.00223-3  1
2013 Baimel C, Borgland SL. Orexin/hypocretin in the Ventral Tegmental Area is Necessary for Morphine-Induced Synaptic Plasticity of Dopamine Neurons Catecholamine Research in the 21st Century: Abstracts and Graphical Abstracts, 10th International Catecholamine Symposium, 2012. 240-241. DOI: 10.1016/B978-0-12-800044-1.00212-9  1
2012 Patyal R, Woo EY, Borgland SL. Local hypocretin-1 modulates terminal dopamine concentration in the nucleus accumbens shell. Frontiers in Behavioral Neuroscience. 6: 82. PMID 23226119 DOI: 10.3389/fnbeh.2012.00082  1
2012 Baimel C, Borgland SL. Hypocretin modulation of drug-induced synaptic plasticity. Progress in Brain Research. 198: 123-31. PMID 22813972 DOI: 10.1016/B978-0-444-59489-1.00008-2  1
2012 Mebel DM, Wong JC, Dong YJ, Borgland SL. Insulin in the ventral tegmental area reduces hedonic feeding and suppresses dopamine concentration via increased reuptake. The European Journal of Neuroscience. 36: 2336-46. PMID 22712725 DOI: 10.1111/j.1460-9568.2012.08168.x  1
2012 Baimel C, Borgland SL, Corrigall W. Cocaine and nicotine research illustrates a range of hypocretin mechanisms in addiction. Vitamins and Hormones. 89: 291-313. PMID 22640620 DOI: 10.1016/B978-0-12-394623-2.00016-0  1
2011 McGinty VB, Hayden BY, Heilbronner SR, Dumont EC, Graves SM, Mirrione MM, du Hoffmann J, Sartor GC, España RA, Millan EZ, Difeliceantonio AG, Marchant NJ, Napier TC, Root DH, Borgland SL, et al. Emerging, reemerging, and forgotten brain areas of the reward circuit: Notes from the 2010 Motivational Neural Networks conference. Behavioural Brain Research. 225: 348-57. PMID 21816177 DOI: 10.1016/j.bbr.2011.07.036  1
2011 Thompson JL, Borgland SL. A role for hypocretin/orexin in motivation. Behavioural Brain Research. 217: 446-53. PMID 20920531 DOI: 10.1016/j.bbr.2010.09.028  1
2010 Borgland SL, Labouèbe G. Orexin/hypocretin in psychiatric disorders: present state of knowledge and future potential. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 353-4. PMID 20010719 DOI: 10.1038/npp.2009.119  1
2010 Borgland SL, Ungless MA, Bonci A. Convergent actions of orexin/hypocretin and CRF on dopamine neurons: Emerging players in addiction. Brain Research. 1314: 139-44. PMID 19891960 DOI: 10.1016/j.brainres.2009.10.068  1
2009 Borgland SL, Chang SJ, Bowers MS, Thompson JL, Vittoz N, Floresco SB, Chou J, Chen BT, Bonci A. Orexin A/hypocretin-1 selectively promotes motivation for positive reinforcers. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 11215-25. PMID 19741128 DOI: 10.1523/JNEUROSCI.6096-08.2009  1
2009 Bonci A, Borgland S. Role of orexin/hypocretin and CRF in the formation of drug-dependent synaptic plasticity in the mesolimbic system. Neuropharmacology. 56: 107-11. PMID 18694770 DOI: 10.1016/j.neuropharm.2008.07.024  1
2008 Borgland SL, Storm E, Bonci A. Orexin B/hypocretin 2 increases glutamatergic transmission to ventral tegmental area neurons. The European Journal of Neuroscience. 28: 1545-56. PMID 18793323 DOI: 10.1111/j.1460-9568.2008.06397.x  1
2008 Richards JK, Simms JA, Steensland P, Taha SA, Borgland SL, Bonci A, Bartlett SE. Inhibition of orexin-1/hypocretin-1 receptors inhibits yohimbine-induced reinstatement of ethanol and sucrose seeking in Long-Evans rats. Psychopharmacology. 199: 109-17. PMID 18470506 DOI: 10.1007/s00213-008-1136-5  1
2007 Sarti F, Borgland SL, Kharazia VN, Bonci A. Acute cocaine exposure alters spine density and long-term potentiation in the ventral tegmental area. The European Journal of Neuroscience. 26: 749-56. PMID 17686047 DOI: 10.1111/j.1460-9568.2007.05689.x  1
2006 de Lecea L, Jones BE, Boutrel B, Borgland SL, Nishino S, Bubser M, DiLeone R. Addiction and arousal: alternative roles of hypothalamic peptides. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 10372-5. PMID 17035520 DOI: 10.1523/JNEUROSCI.3118-06.2006  1
2006 Borgland SL, Taha SA, Sarti F, Fields HL, Bonci A. Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine. Neuron. 49: 589-601. PMID 16476667 DOI: 10.1016/j.neuron.2006.01.016  1
2005 Suvarna N, Borgland SL, Wang J, Phamluong K, Auberson YP, Bonci A, Ron D. Ethanol alters trafficking and functional N-methyl-D-aspartate receptor NR2 subunit ratio via H-Ras. The Journal of Biological Chemistry. 280: 31450-9. PMID 16009711 DOI: 10.1074/jbc.M504120200  1
2004 Borgland SL, Malenka RC, Bonci A. Acute and chronic cocaine-induced potentiation of synaptic strength in the ventral tegmental area: electrophysiological and behavioral correlates in individual rats. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 7482-90. PMID 15329395 DOI: 10.1523/JNEUROSCI.1312-04.2004  1
2003 Borgland SL, Connor M, Osborne PB, Furness JB, Christie MJ. Opioid agonists have different efficacy profiles for G protein activation, rapid desensitization, and endocytosis of mu-opioid receptors. The Journal of Biological Chemistry. 278: 18776-84. PMID 12642578 DOI: 10.1074/jbc.M300525200  1
2002 Borgland SL, Connor M, Ryan RM, Ball HJ, Christie MJ. Prostaglandin E(2) inhibits calcium current in two sub-populations of acutely isolated mouse trigeminal sensory neurons. The Journal of Physiology. 539: 433-44. PMID 11882676 DOI: 10.1113/jphysiol.2001.013322  1
2002 Bowen GP, Borgland SL, Lam M, Libermann TA, Wong NC, Muruve DA. Adenovirus vector-induced inflammation: capsid-dependent induction of the C-C chemokine RANTES requires NF-kappa B. Human Gene Therapy. 13: 367-79. PMID 11860704 DOI: 10.1089/10430340252792503  1
2001 Borgland SL, Connor M, Christie MJ. Nociceptin inhibits calcium channel currents in a subpopulation of small nociceptive trigeminal ganglion neurons in mouse. The Journal of Physiology. 536: 35-47. PMID 11579155 DOI: 10.1111/j.1469-7793.2001.t01-1-00035.x  1
2001 Borgland SL. Acute opioid receptor desensitization and tolerance: is there a link? Clinical and Experimental Pharmacology & Physiology. 28: 147-54. PMID 11207668 DOI: 10.1046/j.1440-1681.2001.03418.x  1
2000 Borgland SL, Bowen GP, Wong NC, Libermann TA, Muruve DA. Adenovirus vector-induced expression of the C-X-C chemokine IP-10 is mediated through capsid-dependent activation of NF-kappaB. Journal of Virology. 74: 3941-7. PMID 10756005 DOI: 10.1128/JVI.74.9.3941-3947.2000  1
1999 Connor M, Borgland SL, Christie MJ. Continued morphine modulation of calcium channel currents in acutely isolated locus coeruleus neurons from morphine-dependent rats. British Journal of Pharmacology. 128: 1561-9. PMID 10602337 DOI: 10.1038/sj.bjp.0702922  1
1998 Borgland SL, Castañón M, Spevak W, Parkinson FE. Effects of propentofylline on adenosine receptor activity in Chinese hamster ovary cell lines transfected with human A1, A2A, or A2B receptors and a luciferase reporter gene. Canadian Journal of Physiology and Pharmacology. 76: 1132-8. PMID 10326835 DOI: 10.1139/cjpp-76-12-1132  1
1998 Borgland SL, Parkinson FE. Effect of adenosine receptor agonists on release of the nucleoside analogue [3H]formycin B from cultured smooth muscle DDT1 MF-2 cells. European Journal of Pharmacology. 346: 339-44. PMID 9652378 DOI: 10.1016/S0014-2999(98)00069-7  1
1997 Borgland SL, Parkinson FE. Uptake and release of [3H]formycin B via sodium-dependent nucleoside transporters in mouse leukemic L1210/MA27.1 cells. The Journal of Pharmacology and Experimental Therapeutics. 281: 347-53. PMID 9103516  1
1996 Borgland SL, Parkinson FE. Sodium-dependent uptake and release of [3H]formycin B in mouse leukemic L1210/MA27.1 cells Proceedings of the Western Pharmacology Society. 39: 94-95.  1
Show low-probability matches.